185 related articles for article (PubMed ID: 17624750)
1. Clara cell 16 protein in COPD sputum: a marker of small airways damage?
Braido F; Riccio AM; Guerra L; Gamalero C; Zolezzi A; Tarantini F; De Giovanni B; Folli C; Descalzi D; Canonica GW
Respir Med; 2007 Oct; 101(10):2119-24. PubMed ID: 17624750
[TBL] [Abstract][Full Text] [Related]
2. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.
Hacievliyagil SS; Gunen H; Mutlu LC; Karabulut AB; Temel I
Respir Med; 2006 May; 100(5):846-54. PubMed ID: 16214322
[TBL] [Abstract][Full Text] [Related]
3. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
Kömüs N; Tertemiz KC; Sevinç C
Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
[TBL] [Abstract][Full Text] [Related]
4. [C-reactive protein level and the correlation between lung function and CRP levels in patients with chronic obstructive pulmonary diseases].
Wu SJ; Chen P; Jiang XN; Liu ZJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 30(4):444-6. PubMed ID: 16190395
[TBL] [Abstract][Full Text] [Related]
5. [Expression and significance of beta(2)-adrenoreceptor in inflammatory cells of patients with chronic obstructive pulmonary disease].
Zhu WJ; He B; Xu M
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2099-102. PubMed ID: 19080468
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive assessment of small airway remodelling in smokers.
Bourdin A; Kotsimbos T; Nguyen K; Vachier I; Mainprice B; Farce M; Paganin F; Marty-Ané C; Vernhet H; Godard P; Chanez P
COPD; 2010 Apr; 7(2):102-10. PubMed ID: 20397810
[TBL] [Abstract][Full Text] [Related]
7. Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD.
Schermer T; Heijdra Y; Zadel S; van den Bemt L; Boonman-de Winter L; Dekhuijzen R; Smeele I
Respir Med; 2007 Jun; 101(6):1355-62. PubMed ID: 17098407
[TBL] [Abstract][Full Text] [Related]
8. Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation.
Dentener MA; Vernooy JH; Hendriks S; Wouters EF
Thorax; 2005 Feb; 60(2):114-9. PubMed ID: 15681498
[TBL] [Abstract][Full Text] [Related]
9. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations.
Papi A; Bellettato CM; Braccioni F; Romagnoli M; Casolari P; Caramori G; Fabbri LM; Johnston SL
Am J Respir Crit Care Med; 2006 May; 173(10):1114-21. PubMed ID: 16484677
[TBL] [Abstract][Full Text] [Related]
10. MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD.
Lowrey GE; Henderson N; Blakey JD; Corne JM; Johnson SR
Respir Med; 2008 Jun; 102(6):845-51. PubMed ID: 18328682
[TBL] [Abstract][Full Text] [Related]
11. [The changes of Clara cell in the distal conducting airways of patients with COPD].
Zhang H; He B; Wang X
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Sep; 24(9):524-6. PubMed ID: 11758164
[TBL] [Abstract][Full Text] [Related]
12. Lung tissue and tumour-infiltrating T lymphocytes in patients with non-small cell lung carcinoma and chronic obstructive pulmonary disease (COPD): moderate/severe versus mild stage of COPD.
Marc MM; Korosec P; Kern I; Sok M; Ihan A; Kosnik M
Scand J Immunol; 2007 Dec; 66(6):694-702. PubMed ID: 17949407
[TBL] [Abstract][Full Text] [Related]
13. Repeatability of inflammatory parameters in induced sputum of COPD patients.
Boorsma M; Lutter R; van de Pol MA; Out TA; Jansen HM; Jonkers RE
COPD; 2007 Dec; 4(4):321-9. PubMed ID: 18027159
[TBL] [Abstract][Full Text] [Related]
14. Enhanced pulmonary leptin expression in patients with severe COPD and asymptomatic smokers.
Vernooy JH; Drummen NE; van Suylen RJ; Cloots RH; Möller GM; Bracke KR; Zuyderduyn S; Dentener MA; Brusselle GG; Hiemstra PS; Wouters EF
Thorax; 2009 Jan; 64(1):26-32. PubMed ID: 18835960
[TBL] [Abstract][Full Text] [Related]
15. [Lung function test for COPD].
Itabashi S
Nihon Rinsho; 2003 Dec; 61(12):2150-7. PubMed ID: 14674325
[TBL] [Abstract][Full Text] [Related]
16. Proposal for a multidimensional staging system for chronic obstructive pulmonary disease.
Celli BR; Calverley PM; Rennard SI; Wouters EF; Agusti A; Anthonisen N; Macnee W; Jones P; Pride N; Rodriguez-Roisin R; Rossi A; Wanner A
Respir Med; 2005 Dec; 99(12):1546-54. PubMed ID: 16291077
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of thyroid hormone levels and somatomedin-C (IGF-1) in patients with chronic obstructive pulmonary disease (COPD) and relation with the severity of the disease.
Coşkun F; Ege E; Uzaslan E; Ediger D; Karadağ M; Gözü O
Tuberk Toraks; 2009; 57(4):369-75. PubMed ID: 20037851
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease.
Demedts IK; Bracke KR; Van Pottelberge G; Testelmans D; Verleden GM; Vermassen FE; Joos GF; Brusselle GG
Am J Respir Crit Care Med; 2007 May; 175(10):998-1005. PubMed ID: 17332482
[TBL] [Abstract][Full Text] [Related]
19. [Elevated substance P content in sputum and plasma in patients with COPD and its relationship with FEV1/FVC].
Tian L; Cai L; Kang J
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Mar; 23(3):138-40. PubMed ID: 11778483
[TBL] [Abstract][Full Text] [Related]
20. 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD.
Kinnula VL; Ilumets H; Myllärniemi M; Sovijärvi A; Rytilä P
Eur Respir J; 2007 Jan; 29(1):51-5. PubMed ID: 17050565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
